Anlotinib in combination with docetaxel for advanced nonsmall cell lung cancer after failure of platinum-based treatment: A phase 1/2 trial. Shou J, Chen J, Guo Q, Hong W, et al. Cancer 2025;131:e35822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shou J, Chen J, Guo Q, Hong W, et al. Anlotinib in combination with docetaxel for advanced nonsmall cell lung cancer after failure of platinum-based treatment: A phase 1/2 trial. Cancer 2025;131:e35822.
PMID: 40366884